Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth D Hinds

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|June 8, 2002
Effects of PEG conjugation on insulin propertiesKenneth D Hinds, Sung Wan Kim
Expert Opinion on Biological Therapy|August 31, 2007
PEGylated bioactive molecules in biodegradable polymer microparticlesPaul G Schmidt, Kathleen M Campbell, Kenneth D Hinds, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 25, 2005
PEGylated insulin in PLGA microparticles. In vivo and in vitro analysisKenneth D Hinds, Kathleen M Campbell, Kathleen M Holland, et al.
Journal of Pharmaceutical Sciences|February 1, 2011
Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodiesTodd J Gibson, Katie Mccarty, Iain J Mcfadyen, et al.
Pharmaceutical Research|May 26, 2018
Considerations for the Use of Polysorbates in BiopharmaceuticalsMichael T Jones, Hanns-Christian Mahler, Sandeep Yadav, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|June 8, 2002
Effects of PEG conjugation on insulin propertiesKenneth D Hinds, Sung Wan Kim
Expert Opinion on Biological Therapy|August 31, 2007
PEGylated bioactive molecules in biodegradable polymer microparticlesPaul G Schmidt, Kathleen M Campbell, Kenneth D Hinds, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 25, 2005
PEGylated insulin in PLGA microparticles. In vivo and in vitro analysisKenneth D Hinds, Kathleen M Campbell, Kathleen M Holland, et al.
Journal of Pharmaceutical Sciences|February 1, 2011
Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodiesTodd J Gibson, Katie Mccarty, Iain J Mcfadyen, et al.
Pharmaceutical Research|May 26, 2018
Considerations for the Use of Polysorbates in BiopharmaceuticalsMichael T Jones, Hanns-Christian Mahler, Sandeep Yadav, et al.
Pageof 1